AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Magenta Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

January 5, 2021 GMT

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan 5, 2021--

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today announced that the company is scheduled to present at the 39 th Annual J.P. Morgan Healthcare Conference, to be held virtually, on Thursday, January 14 th, 2021, at 10:50 a.m. ET, immediately followed by a Q&A session.

ADVERTISEMENT

A live webcast of the presentation and Q&A session can be accessed on the Magenta Therapeutics website at https://investor.magentatx.com/events-and-presentations. The webcast replay will be available for 90 days following the event.

About Magenta Therapeutics

Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of immune system reset through stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant world to revolutionize immune reset for more patients.

Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com.

Follow Magenta on Twitter: @magentatx.

ADVERTISEMENT

View source version on businesswire.com:https://www.businesswire.com/news/home/20210105005204/en/

CONTACT: Lyndsey Scull, Director, Corporate Communications

202-213-7086

lscull@magentatx.comJill Bertotti, W2O Group

714-225-6726

jbertotti@w2ogroup.com

KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH CLINICAL TRIALS

SOURCE: Magenta Therapeutics

Copyright Business Wire 2021.

PUB: 01/05/2021 08:00 AM/DISC: 01/05/2021 08:01 AM

http://www.businesswire.com/news/home/20210105005204/en